Lilium Co-Founder Wiegand Files Amended 13D/A, Maintains Stake

TL;DR

**Lilium co-founder Daniel Wiegand is still holding a big chunk of shares, signaling confidence.**

AI Summary

Daniel Wiegand, a co-founder of Lilium N.V., filed an amended SC 13D/A on January 19, 2024, indicating his continued beneficial ownership of Class A Ordinary Shares. This filing updates his previous disclosures, affirming his significant stake in the company. For investors, this matters because Wiegand's ongoing substantial ownership signals his continued commitment and belief in Lilium's future, which can be a positive indicator of insider confidence.

Why It Matters

This filing confirms a key insider's continued significant ownership, which can influence investor perception of the company's stability and future prospects.

Risk Assessment

Risk Level: low — The filing indicates no significant change in ownership that would introduce new risks, merely an update to existing disclosures.

Analyst Insight

Investors should note that a key insider, Daniel Wiegand, continues to hold a significant stake, which could be interpreted as a sign of confidence in Lilium N.V.'s long-term prospects. This information should be considered alongside other financial and operational data when making investment decisions.

Key Players & Entities

• Daniel Wiegand (person) — Reporting Person, co-founder of Lilium N.V.
• Lilium N.V. (company) — Subject Company, issuer of the securities
• January 19, 2024 (date) — Date of Event which Requires Filing of this Statement
• Class A Ordinary Shares (company) — Title of Class of Securities
• €0.01 (dollar_amount) — nominal value per share

FAQ

Filing Documents

• tm243501d1_sc13da.htm (SC 13D/A) — 36KB
• 0001104659-24-005266.txt ( ) — 38KB

Security and Issuer

Item 1. Security and Issuer

of the Original Schedule

Item 1 of the Original Schedule 13D is hereby amended and restated as follows: This Schedule 13D relates to Class A ordinary shares, €0.01 nominal value per share, and Class B ordinary shares, €0.03 nominal value per share (collectively, the “Ordinary Shares”), of Lilium N.V., a Dutch public limited liability company (the “Company”). The principal executive offices of the Company are located at Claude-Dornier Straße 1, Bldg. 335, 82234 Wessling, Germany.

Identity and Background

Item 2. Identity and Background

, paragraph (c) of

Item 2, paragraph (c) of the Original Schedule 13D is hereby amended and restated as follows: (c) The Reporting Person is the Chief Engineer for Innovation and Future Programs and is an Executive Director of the Company.

Purpose of the Transaction

Item 4. Purpose of the Transaction This Amendment supplements

of the Original Schedule 13D by adding the following

Item 4 of the Original Schedule 13D by adding the following: As of the date of this Amendment, the Reporting Person has converted an aggregate of 1,300,000 Class B ordinary shares into 1,300,000 Class A ordinary shares. In addition, as of the date of this Amendment, the Reporting Person has sold from time to time an aggregate of 1,015,000 Class A ordinary shares in the market pursuant to the 10b5-1 Plan (as defined and described in Item 6 of this Amendment, which is incorporated herein by reference) until its termination on September 6, 2023, which represents approximately 0.4% of the aggregate of 284,110,059 Ordinary Shares outstanding as of September 14, 2021. As result of the issuance of Class A ordinary shares by the Company in connection with a capital raising transaction in November 2022 (which had a final closing on November 29, 2022), the aggregate Ordinary Shares outstanding as of November 22, 2022 (after giving effect to the issuance of all Class A ordinary shares sold in such capital raising transaction) was 392,422,695, consisting of 368,539,630 Class A ordinary shares and 23,883,065 Class B ordinary shares, as reported in the Company’s report on Form 6-K filed with the SEC on November 22, 2022, as compared to the aggregate of 284,110,059 Ordinary Shares, consisting of 259,696,994 Class A ordinary shares and 24,413,065 Class B ordinary shares, that were outstanding as of September 14, 2021. As a result of such increase in the aggregate number of outstanding Ordinary Shares the percentage of Ordinary Shares that the Reporting Person beneficially owned, based on the Reporting Person beneficially owning 24,253,395 Ordinary Shares as of November 30, 2022, decreased from approximately 8.6% to 6.2%. In addition, as a result of the issuance of Class A ordinary shares by the Company in connection with a capital raising transaction in July 2023 (which had a final closing on August 1, 2023), the aggregate Ordinary Shares outstanding as of July 18, 2023 (a

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer This Amendment supplements

of the Original Schedule 13D by adding the following

Item 5 of the Original Schedule 13D by adding the following: (a) The Reporting Person has beneficial ownership of 285,000 Class A ordinary shares and 23,113,065 Class B ordinary shares. The percentage of beneficial ownership is approximately 4.4% of the outstanding Ordinary Shares. The percentage of the Ordinary Shares is based on 526,162,532 Ordinary Shares, consisting of (a) 503,049,467 Class A ordinary shares and (b) 23,113,065 Class B ordinary shares, outstanding as of November 22, 2023, as reported in the registration statement on Form F-3 filed by the Company with the SEC on November 24, 2023. The percentage reported does not reflect the three-for-one voting power of the Class B ordinary shares because these shares are treated as converted into Class A ordinary shares for the purpose of this report. (c) The Reporting Person has not effected any transactions in the Ordinary Shares of the Company in the past 60 days.

Contracts, Arrangements, Understandings

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer This Amendment supplements

of the Original Schedule 13D by adding the following

Item 6 of the Original Schedule 13D by adding the following: On June 10, 2022, the Reporting Person entered into a 10b5-1 plan (the “10b5-1 Plan”), pursuant to which an aggregate of 1,015,000 Class A ordinary shares were sold. The 10b5-1 Plan was terminated on September 6, 2023, with the last sale pursuant thereto occurring on February 21, 2023. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 19, 2024 By: /s/ Daniel Wiegand Name: Daniel Wiegand Title: Executive Director

View Full Filing

View this SC 13D/A filing on SEC EDGAR